Cargando…

Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantation

Outcomes after hematopoietic stem cell transplantation (HSCT) for patients with both malignant and nonmalignant diseases have improved significantly in recent years. However, the endocrine system is highly susceptible to damage by the high-dose chemotherapy and/or irradiation used in the conditionin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cima, Luminita Nicoleta, Colita, Anca, Fica, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655684/ https://www.ncbi.nlm.nih.gov/pubmed/28947558 http://dx.doi.org/10.1530/EC-17-0246

Ejemplares similares

Fertility preservation and GnRHa for chemotherapy: debate
por: Blumenfeld, Zeev
Publicado: (2014)

GnRHa trigger—the story of the ugly duckling
por: Humaidan, Peter, et al.
Publicado: (2023)

The Luteal Phase after GnRHa Trigger-Understanding An Enigma
por: Leth-Moller, Kathrine, et al.
Publicado: (2014)

Empty Follicle Syndrome Following GnRHa Trigger in PCOS Patients Undergoing IVF Cycles
por: Deepika, Krishna, et al.
Publicado: (2018)

Treatment of central precocious puberty using low dose GnRH analogs (GnRHa)
por: Jahagirdar, Rahul, et al.
Publicado: (2015)

A single sample GnRHa stimulation test in the diagnosis of precocious puberty
por: Yazdani, Parvin, et al.
Publicado: (2012)

Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone
por: Agarwal, Sanjay K., et al.
Publicado: (2015)

Comparison of Clinical Efficacy between a Single Administration of Long-Acting Gonadotrophin-Releasing Hormone Agonist (GnRHa) and Daily Administrations of Short-Acting GnRHa in In Vitro Fertilization-Embryo Transfer Cycles
por: Cheon, Kang Woo, et al.
Publicado: (2008)

Experience with the once-yearly histrelin (GnRHa) subcutaneous implant in the treatment of central precocious puberty
por: Lewis, Katherine A, et al.
Publicado: (2009)

Curative GnRHa treatment has an unexpected repressive effect on Sertoli cell specific genes
por: Gegenschatz-Schmid, Katharina, et al.
Publicado: (2018)

GnRHa Before Single-Port Laparoscopic Hysterectomy in a Large Barrel-Shaped Uterus
por: Torng, Pao-Ling, et al.
Publicado: (2019)

Testicular expression of long non–coding RNAs is affected by curative GnRHa treatment of cryptorchidism
por: Hadziselimovic, Faruk, et al.
Publicado: (2019)

GnRHa/Stanozolol Combined Therapy Maintains Normal Bone Growth in Central Precocious Puberty
por: Zhu, Shunye, et al.
Publicado: (2021)

Effects of GnRHa treatment during vitellogenesis on the reproductive physiology of thermally challenged female Atlantic salmon (Salmo salar)
por: Anderson, Kelli, et al.
Publicado: (2017)

Graves’ orbitopathy after allogeneic bone marrow transplantation in a patient with Fanconi anemia – side effect of alemtuzumab therapy?
por: Cima, Luminita Nicoleta, et al.
Publicado: (2018)

The Efficacy of GnRHa Alone or in Combination with rhGH for the Treatment of Chinese Children with Central Precocious Puberty
por: Wang, Mengjie, et al.
Publicado: (2016)

GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
por: Li, Xiaolin, et al.
Publicado: (2021)

GnRHa for Ovarian Protection and the Association between AMH and Ovarian Function during Adjuvant Chemotherapy for Breast Cancer
por: Zhong, Ying, et al.
Publicado: (2019)

Expression profiles of E/P receptors and fibrosis in GnRHa-treated and -untreated women with different uterine leiomyomas
por: Khan, Khaleque N., et al.
Publicado: (2020)

GnRHa as a treatment for letrozole-resistant recurrent adult granulosa cell tumors: A case report
por: Zhuang, Yuan, et al.
Publicado: (2021)

Effect of recombinant LH supplementation timing on clinical pregnancy outcome in long-acting GnRHa downregulated cycles
por: Huang, Chenyang, et al.
Publicado: (2022)

Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses
por: Rodrigues, Rosane S., et al.
Publicado: (2014)

Just as Tall on Testosterone; a Neutral to Positive Effect on Adult Height of GnRHa and Testosterone in Trans Boys
por: Willemsen, Lieve Anne, et al.
Publicado: (2022)

Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells
por: Luo, Xiaoping, et al.
Publicado: (2003)

Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis
por: de Milliano, Inge, et al.
Publicado: (2017)

Growth, bone maturation and ovarian size in girls with early and fast puberty (EFP) and effects of three years treatment with GnRH analogue (GnRHa)
por: Alaaraj, Nada, et al.
Publicado: (2021)

Development of Hip Bone Geometry in Transgender Adolescents Resembles the Experienced Gender if GnRHa Treatment Is Started in Early, but Not Late, Puberty
por: van der Loos, Maria A T C, et al.
Publicado: (2021)

Response of South Indian girls with central precocious puberty to gonadotrophin analogue (GnRHa) therapy – a single center experience
por: Selvaraj, Meghana, et al.
Publicado: (2021)

MTHFR 677TT is associated with decreased number of embryos and cumulative live birth rate in patients undergoing GnRHa short protocol: a retrospective study
por: Zeng, Hong, et al.
Publicado: (2022)

Safety and efficacy concerns of long-acting GnRHa trigger for ovulation induction in oncological patients undergoing oocyte cryopreservation: a call for caution and further investigation
por: Ingold, C., et al.
Publicado: (2023)

Retraction Note to: Gonadotropin releasing hormone analogue (GnRHa) alters the expression and activation of Smad in human endometrial epithelial and stromal cells
por: Luo, Xiaoping, et al.
Publicado: (2015)

Comparison Between PPOS and GnRHa-Long Protocol in Clinical Outcome with the First IVF/ICSI Cycle: A Randomized Clinical Trial
por: Xi, Qianwen, et al.
Publicado: (2020)

OR15-01 Blockers and Bones: Loss of Absolute Bone Mineral Density Is Common in Trans- and Gender- Diverse Adolescents Treated with GnRHa
por: Ferguson, Grant, et al.
Publicado: (2020)

STROBE-GnRHa pretreatment in frozen-embryo transfer cycles improves clinical outcomes for patients with persistent thin endometrium: A case-control study
por: Liu, Yixuan, et al.
Publicado: (2022)

Transdermal versus oral estrogen: clinical outcomes in patients undergoing frozen-thawed single blastocyst transfer cycles without GnRHa suppression, a prospective randomized clinical trial
por: Kahraman, Semra, et al.
Publicado: (2018)

HCG Trigger of GnRH Agonist-Induced Functional Ovarian Cysts Does Not Decrease Clinical Pregnancy Rate in GnRHa Pretreated Frozen Cycles: Evidence From a Retrospective Cohort Study
por: Zeng, Hong, et al.
Publicado: (2022)

Central Precocious Puberty and Response to GnRHa Therapy in Children with Cerebral Palsy and Moderate to Severe Motor Impairment: Data from a Longitudinal, Case-Control, Multicentre, Italian Study
por: Bruzzi, Patrizia, et al.
Publicado: (2017)

Additional single dose GnRH agonist during luteal phase support may improve live birth rate in GnRHa-HRT frozen–thawed embryo transfer cycle: a retrospective cohort study
por: Chang, Wei-Shan, et al.
Publicado: (2023)

Long-term effects and significant adverse drug reactions (ADRs) associated with the use of gonadotropin-releasing hormone analogs (GnRHa) for central precocious puberty: a brief review of literature
por: De Sanctis, Vincenzo, et al.
Publicado: (2019)

Effect of Exogenous Luteinizing Hormone (LH) Supplementation on Clinical Pregnancy of Patients Receiving Long-Acting Gonadotropin-Releasing Hormone Agonist (GnRHa) Cycles: A Retrospective Cohort Study
por: Huang, Chenyang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tegloigterm8o7optojiiekl19